Fish oil and Aspirin-Like drug may ease diabetic nerve pain
NCT ID NCT05169060
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early study tests whether fish oil, alone or with salsalate (an anti-inflammatory drug), can improve blood markers linked to nerve health in people with type 2 diabetes and diabetic neuropathy. About 100 adults will take fish oil capsules for 4 months, then add salsalate for 2 more months. The goal is to see if this combination safely increases anti-inflammatory substances in the blood, which could eventually lead to a treatment for nerve damage.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Fish oil and salsalate
What this could lead to
If it works, this could point toward a new treatment for diabetic nerve pain and damage.
What could go wrong
This is a very early, small study (100 people) looking at blood markers, not symptoms. The combination may not actually help nerve pain or could cause side effects like stomach issues.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Oregon Health Science University
Portland, Oregon, 97239, United States
-
University of Iowa
Iowa City, Iowa, 52241, United States